TG Therapeutics
$8.959876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$8.95
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.48 (-5.09%) Today
$0.00 (0.00%) As of 6:30 PM EDT after-hours
Why Robinhood?
You can buy or sell TGTX and other stocks, options, ETFs, and crypto commission-free!
About TGTX
TG Therapeutics, Inc. Common Stock, also called TG Therapeutics, is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Read More Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY.
Employees
134
Headquarters
New York, New York
Founded
1993
Market Cap
973.67M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
2.18M
High Today
$9.53
Low Today
$8.82
Open Price
$9.36
Volume
815.90K
52 Week High
$16.22
52 Week Low
$4.95
Collections
TGTX Earnings
-$0.69
-$0.46
-$0.23
$0.00
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Estimated
— per share
Actual
Expected May 8, After Hours